Total Payments
$661.87
2024 Payments
$27.29
Companies
8
Transactions
35

Payment Breakdown by Category

Food & Beverage$661.87 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $661.87 35 100.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $321.07 25 $0 (2022)
Boston Scientific Corporation $124.89 1 $0 (2022)
GENZYME CORPORATION $54.42 2 $0 (2022)
ABBVIE INC. $49.30 2 $0 (2023)
Cumberland Pharmaceuticals, Inc. $41.15 2 $0 (2022)
Ascendis Pharma Inc $27.29 1 $0 (2024)
Nestle HealthCare Nutrition Inc. $22.37 1 $0 (2022)
Travere Therapeutics, Inc. $21.38 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $27.29 1 Ascendis Pharma Inc ($27.29)
2023 $27.15 1 ABBVIE INC. ($27.15)
2022 $312.81 8 Boston Scientific Corporation ($124.89)
2020 $43.53 2 AbbVie Inc. ($22.15)
2019 $103.88 7 Takeda Pharmaceuticals U.S.A., Inc. ($103.88)
2018 $70.81 7 Takeda Pharmaceuticals U.S.A., Inc. ($70.81)
2017 $76.40 9 Takeda Pharmaceuticals U.S.A., Inc. ($76.40)

All Payment Transactions

35 individual payment records from CMS Open Payments — Page 2 of 2

Date Company Product Nature Form Amount Type
02/14/2018 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $7.17 General
Category: Lower GI
11/29/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $9.66 General
Category: Lower GI
11/29/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $7.25 General
Category: Lower GI
11/09/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $10.14 General
Category: Lower GI
11/08/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $9.33 General
Category: Lower GI
04/28/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $7.09 General
Category: Lower GI
04/26/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $6.57 General
Category: Lower GI
02/22/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $10.51 General
Category: Lower GI
02/22/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $8.85 General
Category: Lower GI
01/04/2017 Takeda Pharmaceuticals U.S.A., Inc. Entyvio (Biological) Food and Beverage In-kind items and services $7.00 General
Category: Lower GI

About Dr. Mira Kothari, MD

Dr. Mira Kothari, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2012. The National Provider Identifier (NPI) number assigned to this provider is 1710246426.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mira Kothari, MD has received a total of $661.87 in payments from pharmaceutical and medical device companies, with $27.29 received in 2024. These payments were reported across 35 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($661.87).

Practice Information

Products in Payments

  • Entyvio (Biological) $251.09
  • WATCHMAN Access System (Device) $124.89
  • GATTEX (Drug) $69.98
  • DUPIXENT (Biological) $54.42
  • KRISTALOSE (Drug) $41.15
  • Skytrofa (Drug) $27.29
  • SKYRIZI (Biological) $27.15
  • ZENPEP (Drug) $22.37
  • HUMIRA (Biological) $22.15
  • (820) Cholbam (Drug) $21.38

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Valhalla